What you should know about PR3-ANCA - Structural aspects of antibodies to proteinase 3 (PR3)

被引:9
作者
Peen, E [1 ]
Williams, RC
机构
[1] Univ Bergen, Haukeland Hosp, Dept Med, Div Rheumatol, N-5021 Bergen, Norway
[2] Univ New Mexico, Sch Med, Dept Med, Div Rheumatol, Albuquerque, NM 87131 USA
关键词
anti-neutrophil cytoplasmic antibodies; proteinase; 3; three dimensional structure of proteinase 3; antiproteinase; antibodies; Wegener's granulomatosis;
D O I
10.1186/ar97
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reactive antigenic epitopes on presumed autoantigens of biologic interest have been examined by many researchers. The central third complementarity-determining region (CDR3) residues of a human monoclonal anti-proteinase 3 (PR3) antibody contained many negatively charged aspartic acid residues, perhaps contributing to its reactivity with positively charged PR3 regions. Examination of four other human monoclonal anti-PR3 antibodies shows a number of negatively charged residues within their CDR3 regions. Mapping of segments of linear PR3-epitopes reacting with anti-neutrophil cytoplasmic antibodies (ANCA) demonstrated a preliminary estimate of structures contributing to antigenic determinants. T-cell epitopes on PR3 are reported in studies of chronic myeloid leukemia. These T-cell epitopes appear to be human leukocyte antigen (HLA) A2.1 restricted.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 18 条
[1]  
BINI P, 1992, J IMMUNOL, V149, P1409
[2]  
CHANG L, 1995, CLIN EXP IMMUNOL, V102, P112
[3]   Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction [J].
Corper, AL ;
Sohi, MK ;
Bonagura, VR ;
Steinitz, M ;
Jefferis, R ;
Feinstein, A ;
Beale, D ;
Taussig, MJ ;
Sutton, BJ .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (05) :374-381
[4]   Determination of primary amino acid sequence and unique three-dimensional structure of WGH1, a monoclonal human IgM antibody with anti-PR3 specificity [J].
Davis, JA ;
Peen, E ;
Williams, RC ;
Perkins, S ;
Malone, CC ;
McCormack, WT ;
Csernok, E ;
Gross, WL ;
Kolaskar, AS ;
Kulkarni-Kale, U .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 89 (01) :35-43
[5]   The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies [J].
Fujinaga, M ;
Chernaia, MM ;
Halenbeck, R ;
Koths, K ;
James, MNG .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (02) :267-278
[6]   WEGENER GRANULOMATOSIS AUTOANTIBODIES IDENTIFY A NOVEL DIISOPROPYLFLUOROPHOSPHATE BINDING-PROTEIN IN THE LYSOSOMES OF NORMAL HUMAN-NEUTROPHILS [J].
GOLDSCHMEDING, R ;
VANDERSCHOOT, CE ;
HUININK, DT ;
HACK, CE ;
VANDENENDE, ME ;
KALLENBERG, CGM ;
VONDEMBORNE, AEGK .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1577-1587
[7]  
Harmsen MC, 1997, CLIN EXP IMMUNOL, V110, P257
[8]   Targeted T-cell therapy for human leukemia: Cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells [J].
Molldrem, J ;
Dermime, S ;
Parker, K ;
Jiang, YZ ;
Mavroudis, D ;
Hensel, N ;
Fukushima, P ;
Barrett, AJ .
BLOOD, 1996, 88 (07) :2450-2457
[9]   Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units [J].
Molldrem, JJ ;
Clave, E ;
Jiang, YZ ;
Mavroudis, D ;
Raptis, A ;
Hensel, N ;
Agarwala, V ;
Barrett, AJ .
BLOOD, 1997, 90 (07) :2529-2534
[10]  
Sibilia J, 1997, J IMMUNOL, V159, P712